Elevance Health, Inc.
Close on Nov 2, 2026Market cap $89.70BP/E 18.4Yield –
Elevance Health Total Carelon (CarelonRx + Carelon Services) by Quarter
Total Carelon (CarelonRx + Carelon Services) — Operating Revenue ($M)
Elevance Health Total Carelon (CarelonRx + Carelon Services): $19,307M in Q3 2026, up 5.4% from a year earlier. That is the highest of the 19 quarters on record here.
Where the Q3 2026 figure comes from
“|| Operating revenue - total | $ | 43,357 | $ | 11,599 | $ | 7,708 | $ | 19,307 | $ | 6 | $ | ( 12,230 ) | $ | 50,440”
Source: 10-Q (2026-10-21) ↗
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Total Carelon (CarelonRx + Carelon Services) — Operating Revenue ($M) | Year on year | Source |
|---|---|---|---|---|
| Q3 2026 | Sep 30, 2026 | 19,307 | +5.4% | 10-Q (2026-10-21) ↗ |
| Q2 2026 | Jun 30, 2026 | 19,225 | +6.3% | 10-Q (2026-07-15) ↗ |
| Q1 2026 | Mar 31, 2026 | 17,965 | +7.9% | 10-Q (2026-04-22) ↗ |
| Q4 2025 | Dec 31, 2025 | 18,659 | +26.5% | Derived Q4 = FY2025 (10-K (FY2025, 2026-02-06)) − 9M2025 (10-Q (2026-10-21)) ↗ |
| Q3 2025 | Sep 30, 2025 | 18,321 | +32.9% | 10-Q (2026-10-21) ↗ |
| Q2 2025 | Jun 30, 2025 | 18,084 | +35.8% | 10-Q (2026-07-15) ↗ |
| Q1 2025 | Mar 31, 2025 | 16,652 | +37.9% | 10-Q (2026-04-22) ↗ |
| Q4 2024 | Dec 31, 2024 | 14,746 | +18.9% | Derived Q4 = FY2024 (10-K (FY2025, 2026-02-06)) − 9M2024 (10-Q (2025-10-21)) ↗ |
| Q3 2024 | Sep 30, 2024 | 13,781 | +14.6% | 10-Q (2025-10-21) ↗ |
| Q2 2024 | Jun 30, 2024 | 13,319 | +10.3% | 10-Q (2025-07-17) ↗ |
| Q1 2024 | Mar 31, 2024 | 12,076 | +5.2% | 10-Q (2025-04-22) ↗ |
| Q4 2023 | Dec 31, 2023 | 12,401 | +9.8% | Derived Q4 = FY2023 (10-K (FY2025, 2026-02-06)) − 9M2023 (10-Q (2024-10-17)) ↗ |
| Q3 2023 | Sep 30, 2023 | 12,027 | +15.6% | 10-Q (2024-10-17) ↗ |
| Q2 2023 | Jun 30, 2023 | 12,070 | +20.1% | 10-Q (2024-07-17) ↗ |
| Q1 2023 | Mar 31, 2023 | 11,484 | +19.2% | 10-Q (2024-04-18) ↗ |
| Q4 2022 | Dec 31, 2022 | 11,298 | – | Derived Q4 = FY2022 (10-K (FY2024, 2025-02-20)) − 9M2022 (10-Q (2023-10-18)) ↗ |
| Q3 2022 | Sep 30, 2022 | 10,403 | – | 10-Q (2023-10-18) ↗ |
| Q2 2022 | Jun 30, 2022 | 10,054 | – | 10-Q (2023-07-19) ↗ |
| Q1 2022 | Mar 31, 2022 | 9,631 | – | 10-Q (2023-04-19) ↗ |
Breakdown
What makes up total Carelon (CarelonRx + Carelon Services)
- CarelonRx Segment — Total Operating Revenue11,599 · Q3 2026
- Carelon Services Segment — Total Operating Revenue7,708 · Q3 2026
- Total Carelon — Unaffiliated (External Third-Party) Operating Revenue7,330 · Q3 2026
- Total Carelon — Affiliated (Intersegment) Operating Revenue11,977 · Q3 2026
- Total Carelon — Segment Benefit Expense (ASU 2023-07)6,521 · Q3 2026
- Total Carelon — Cost of Products Sold (ASU 2023-07)10,779 · Q3 2026
- Total Carelon — Segment Operating Expense (ASU 2023-07)1,099 · Q3 2026
Cite this data
StockData. (2026). Elevance Health Total Carelon (CarelonRx + Carelon Services) ($M), quarterly Q1 2022–Q3 2026 [Data set]. Compiled from Elevance Health SEC filings and investor materials. https://stockdatahq.com/stocks/elv/kpis/seg-rev-carelon-total
See every metric in the Elevance Health KPI table. Data updated Oct 28, 2026.